Hartland & Co »

Aclaris Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $2 1 2.00

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
Vanguard Group
BlackRock
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Morgan Stanley
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
Renaissance Technologies
Palo Alto Investors
Millennium Management

View all funds holding Aclaris Therapeutics